Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 313

1.

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

Tiemann K, Garri C, Lee SB, Malihi PD, Park M, Alvarez RM, Yap LP, Mallick P, Katz JE, Gross ME, Kani K.

Oncogene. 2018 Dec 21. doi: 10.1038/s41388-018-0638-9. [Epub ahead of print]

PMID:
30575818
2.

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer.

Rodríguez-Blanco G, Zeneyedpour L, Duijvesz D, Hoogland AM, Verhoef EI, Kweldam CF, Burgers PC, Smitt PS, Bangma CH, Jenster G, van Leenders GJLH, Dekker LJM, Luider TM.

Oncotarget. 2018 Nov 23;9(92):36444-36456. doi: 10.18632/oncotarget.26342. eCollection 2018 Nov 23.

3.

Impact of Community-Onset Methicillin-Resistant Staphylococcus aureus on Staphylococcus aureus Bacteremia in a Central Korea Veterans Health Service Hospital.

Bae E, Kim CK, Jang JH, Sung H, Choi Y, Kim MN.

Ann Lab Med. 2019 Mar;39(2):158-166. doi: 10.3343/alm.2019.39.2.158.

4.

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma.

Kim J, Chung JY, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH, Hewitt SM.

Front Oncol. 2018 Oct 23;8:465. doi: 10.3389/fonc.2018.00465. eCollection 2018.

5.

Characterization of Panton-Valentine leukocidin-positive Staphylococcus aureus from skin and soft tissue infections and wounds in Nigeria: a cross-sectional study.

Ayepola OO, Olasupo NA, Egwari LO, Schaumburg F.

F1000Res. 2018 Jul 30;7:1155. doi: 10.12688/f1000research.15484.1. eCollection 2018.

6.

RAD9A promotes metastatic phenotypes through transcriptional regulation of Anterior Gradient 2 (AGR2).

Broustas CG, Hopkins KM, Panigrahi SK, Wang L, Virk RK, Lieberman HB.

Carcinogenesis. 2018 Oct 6. doi: 10.1093/carcin/bgy131. [Epub ahead of print]

PMID:
30295739
7.

Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes.

Kanno A, Asahara SI, Kawamura M, Furubayashi A, Tsuchiya S, Suzuki E, Takai T, Koyanagi-Kimura M, Matsuda T, Okada Y, Ogawa W, Kido Y.

J Diabetes Investig. 2018 Oct 5. doi: 10.1111/jdi.12945. [Epub ahead of print]

8.

The role of protein disulphide isomerase AGR2 in the tumour niche.

Delom F, Nazaraliyev A, Fessart D.

Biol Cell. 2018 Dec;110(12):271-282. doi: 10.1111/boc.201800024. Epub 2018 Oct 14. Review.

9.

miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.

Pan B, Yang J, Wang X, Xu K, Ikezoe T.

Exp Hematol. 2018 Dec;68:80-88.e2. doi: 10.1016/j.exphem.2018.09.001. Epub 2018 Sep 5.

PMID:
30195077
10.

Robust identification of target genes and outliers in triple-negative breast cancer data.

Segaert P, Lopes MB, Casimiro S, Vinga S, Rousseeuw PJ.

Stat Methods Med Res. 2018 Aug 27:962280218794722. doi: 10.1177/0962280218794722. [Epub ahead of print]

PMID:
30146936
11.

High AGR2 protein is a feature of low grade endometrial cancer cells.

Kamal A, Valentijn A, Barraclough R, Rudland P, Rahmatalla N, Martin-Hirsch P, Stringfellow H, Decruze SB, Hapangama DK.

Oncotarget. 2018 Jul 31;9(59):31459-31472. doi: 10.18632/oncotarget.25838. eCollection 2018 Jul 31.

12.

Anterior gradient 2 as a supervisory marker for tumor vessel normalization induced by anti-angiogenic treatment.

Pan F, Li W, Yang W, Yang XY, Liu S, Li X, Zhao X, Ding H, Qin L, Pan Y.

Oncol Lett. 2018 Sep;16(3):3083-3091. doi: 10.3892/ol.2018.8996. Epub 2018 Jun 20.

13.

Antisense oligonucleotide targeting of mRNAs encoding ENaC subunits α, β, and γ improves cystic fibrosis-like disease in mice.

Zhao C, Crosby J, Lv T, Bai D, Monia BP, Guo S.

J Cyst Fibros. 2018 Aug 10. pii: S1569-1993(18)30703-3. doi: 10.1016/j.jcf.2018.07.006. [Epub ahead of print]

PMID:
30100257
14.

An aberrantly spliced isoform of anterior gradient-2, AGR2vH promotes migration and invasion of cholangiocarcinoma cell.

Yosudjai J, Inpad C, Chomwong S, Dana P, Sawanyawisuth K, Phimsen S, Wongkham S, Jirawatnotai S, Kaewkong W.

Biomed Pharmacother. 2018 Nov;107:109-116. doi: 10.1016/j.biopha.2018.07.154. Epub 2018 Aug 4.

PMID:
30086457
15.

Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Curtarelli RB, Gonçalves JM, Dos Santos LGP, Savi MG, Nör JE, Mezzomo LAM, Rodríguez Cordeiro MM.

Stem Cell Rev. 2018 Dec;14(6):769-784. doi: 10.1007/s12015-018-9839-4. Review.

PMID:
30076557
16.

Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.

Liu QG, Li YJ, Yao L.

Pancreatology. 2018 Sep;18(6):678-688. doi: 10.1016/j.pan.2018.07.003. Epub 2018 Jul 7.

PMID:
30055941
17.

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer.

Josefsson A, Larsson K, Månsson M, Björkman J, Rohlova E, Åhs D, Brisby H, Damber JE, Welén K.

Oncotarget. 2018 Jun 29;9(50):29403-29413. doi: 10.18632/oncotarget.25634. eCollection 2018 Jun 29.

18.

Crystal structure of human anterior gradient protein 3.

Nguyen VD, Biterova E, Salin M, Wierenga RK, Ruddock LW.

Acta Crystallogr F Struct Biol Commun. 2018 Jul 1;74(Pt 7):425-430. doi: 10.1107/S2053230X18009093. Epub 2018 Jun 26.

PMID:
29969106
19.

Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2).

Garri C, Howell S, Tiemann K, Tiffany A, Jalali-Yazdi F, Alba MM, Katz JE, Takahashi TT, Landgraf R, Gross ME, Roberts RW, Kani K.

Oncotarget. 2018 Jun 8;9(44):27363-27379. doi: 10.18632/oncotarget.25221. eCollection 2018 Jun 8.

20.

Downregulation of AGR2, p21, and cyclin D and alterations in p53 function were associated with tumor progression and chemotherapy resistance in epithelial ovarian carcinoma.

Alves MR, E Melo NC, Barros-Filho MC, do Amaral NS, Silva FIB, Baiocchi Neto G, Soares FA, de Brot Andrade L, Rocha RM.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1530. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center